TH588, an MTH1 inhibitor, enhances phenethyl isothiocyanate-induced growth inhibition in pancreatic cancer cells.
Saved in:
| Title: | TH588, an MTH1 inhibitor, enhances phenethyl isothiocyanate-induced growth inhibition in pancreatic cancer cells. |
|---|---|
| Authors: | Ikejiri F; The Department of Oncology/Hematology, Faculty of Medicine, Shimane University, Izumo, Shimane 693-8501, Japan., Honma Y; The Department of Oncology/Hematology, Faculty of Medicine, Shimane University, Izumo, Shimane 693-8501, Japan.; The Department of Biochemistry, Faculty of Medicine, Shimane University, Izumo, Shimane 693-8501, Japan., Kasukabe T; The Department of Medical Education and Research, Faculty of Medicine, Shimane University, Izumo, Shimane 693-8501, Japan., Urano T; The Department of Biochemistry, Faculty of Medicine, Shimane University, Izumo, Shimane 693-8501, Japan., Suzumiya J; The Department of Oncology/Hematology, Faculty of Medicine, Shimane University, Izumo, Shimane 693-8501, Japan. |
| Source: | Oncology letters [Oncol Lett] 2018 Mar; Vol. 15 (3), pp. 3240-3244. Date of Electronic Publication: 2017 Dec 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Spandidos Publications] Country of Publication: Greece NLM ID: 101531236 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1792-1074 (Print) Linking ISSN: 17921074 NLM ISO Abbreviation: Oncol Lett Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
